Logo image of ULBI

ULTRALIFE CORP (ULBI) Stock Fundamental Analysis

NASDAQ:ULBI - US9038991025 - Common Stock

7.21 USD
+0.55 (+8.26%)
Last: 8/22/2025, 8:00:02 PM
7.3 USD
+0.09 (+1.25%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

5

Taking everything into account, ULBI scores 5 out of 10 in our fundamental rating. ULBI was compared to 93 industry peers in the Electrical Equipment industry. ULBI has only an average score on both its financial health and profitability. ULBI scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, ULBI could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ULBI had positive earnings in the past year.
ULBI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ULBI reported negative net income in multiple years.
ULBI had a positive operating cash flow in 4 of the past 5 years.
ULBI Yearly Net Income VS EBIT VS OCF VS FCFULBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.45%, ULBI is in the better half of the industry, outperforming 69.89% of the companies in the same industry.
ULBI has a better Return On Equity (2.31%) than 67.74% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.75%, ULBI is in the better half of the industry, outperforming 69.89% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ULBI is significantly below the industry average of 10.01%.
The 3 year average ROIC (3.14%) for ULBI is below the current ROIC(3.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.45%
ROE 2.31%
ROIC 3.75%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ULBI Yearly ROA, ROE, ROICULBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

ULBI has a better Profit Margin (1.79%) than 70.97% of its industry peers.
In the last couple of years the Profit Margin of ULBI has declined.
ULBI's Operating Margin of 5.14% is fine compared to the rest of the industry. ULBI outperforms 70.97% of its industry peers.
ULBI's Operating Margin has been stable in the last couple of years.
ULBI has a Gross Margin (24.39%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ULBI has declined.
Industry RankSector Rank
OM 5.14%
PM (TTM) 1.79%
GM 24.39%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
ULBI Yearly Profit, Operating, Gross MarginsULBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

ULBI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ULBI has more shares outstanding
The number of shares outstanding for ULBI has been increased compared to 5 years ago.
The debt/assets ratio for ULBI is higher compared to a year ago.
ULBI Yearly Shares OutstandingULBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ULBI Yearly Total Debt VS Total AssetsULBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 1.99 indicates that ULBI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.99, ULBI perfoms like the industry average, outperforming 59.14% of the companies in the same industry.
The Debt to FCF ratio of ULBI is 3.67, which is a good value as it means it would take ULBI, 3.67 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.67, ULBI is doing good in the industry, outperforming 77.42% of the companies in the same industry.
ULBI has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
ULBI has a Debt to Equity ratio (0.34) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.67
Altman-Z 1.99
ROIC/WACC0.49
WACC7.58%
ULBI Yearly LT Debt VS Equity VS FCFULBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 3.31 indicates that ULBI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.31, ULBI is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
A Quick Ratio of 1.62 indicates that ULBI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.62, ULBI is in the better half of the industry, outperforming 62.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 1.62
ULBI Yearly Current Assets VS Current LiabilitesULBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

ULBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.61%.
Measured over the past 5 years, ULBI shows a small growth in Earnings Per Share. The EPS has been growing by 3.31% on average per year.
The Revenue has been growing slightly by 5.86% in the past year.
Measured over the past years, ULBI shows a quite strong growth in Revenue. The Revenue has been growing by 9.02% on average per year.
EPS 1Y (TTM)-67.61%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-68.18%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%12.98%

3.2 Future

The Earnings Per Share is expected to grow by 43.60% on average over the next years. This is a very strong growth
ULBI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.34% yearly.
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

8

4. Valuation

4.1 Price/Earnings Ratio

ULBI is valuated quite expensively with a Price/Earnings ratio of 31.35.
ULBI's Price/Earnings ratio is a bit cheaper when compared to the industry. ULBI is cheaper than 74.19% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.24. ULBI is around the same levels.
With a Price/Forward Earnings ratio of 7.60, the valuation of ULBI can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ULBI indicates a rather cheap valuation: ULBI is cheaper than 98.92% of the companies listed in the same industry.
ULBI is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.35
Fwd PE 7.6
ULBI Price Earnings VS Forward Price EarningsULBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ULBI is valued cheaply inside the industry as 90.32% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ULBI is valued cheaper than 96.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.63
EV/EBITDA 11.31
ULBI Per share dataULBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

ULBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ULBI's earnings are expected to grow with 43.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)9.48
EPS Next 2Y43.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ULBI!.
Industry RankSector Rank
Dividend Yield N/A

ULTRALIFE CORP

NASDAQ:ULBI (8/22/2025, 8:00:02 PM)

After market: 7.3 +0.09 (+1.25%)

7.21

+0.55 (+8.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners73.53%
Inst Owner Change-0.43%
Ins Owners3.17%
Ins Owner Change1.44%
Market Cap119.97M
Analysts82.86
Price Target14.28 (98.06%)
Short Float %1.16%
Short Ratio1.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-33.01%
Min EPS beat(2)-50.98%
Max EPS beat(2)-15.03%
EPS beat(4)0
Avg EPS beat(4)-62.53%
Min EPS beat(4)-93.46%
Max EPS beat(4)-15.03%
EPS beat(8)3
Avg EPS beat(8)0.49%
EPS beat(12)5
Avg EPS beat(12)43.66%
EPS beat(16)7
Avg EPS beat(16)37.65%
Revenue beat(2)1
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-6.65%
Max Revenue beat(2)3.65%
Revenue beat(4)2
Avg Revenue beat(4)-3.53%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)7.48%
Revenue beat(8)5
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)3.79%
Revenue beat(16)10
Avg Revenue beat(16)3.23%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.38%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 31.35
Fwd PE 7.6
P/S 0.67
P/FCF 8.63
P/OCF 7.02
P/B 0.87
P/tB 1.73
EV/EBITDA 11.31
EPS(TTM)0.23
EY3.19%
EPS(NY)0.95
Fwd EY13.16%
FCF(TTM)0.84
FCFY11.59%
OCF(TTM)1.03
OCFY14.25%
SpS10.75
BVpS8.32
TBVpS4.16
PEG (NY)0.46
PEG (5Y)9.48
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 2.31%
ROCE 4.81%
ROIC 3.75%
ROICexc 3.98%
ROICexgc 6.46%
OM 5.14%
PM (TTM) 1.79%
GM 24.39%
FCFM 7.77%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)5.27%
ROICexgc(5y)N/A
ROCE(3y)4.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.06%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.19%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
F-Score3
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.67
Debt/EBITDA 3.36
Cap/Depr 64.6%
Cap/Sales 1.79%
Interest Coverage 250
Cash Conversion 120.88%
Profit Quality 434.92%
Current Ratio 3.31
Quick Ratio 1.62
Altman-Z 1.99
F-Score3
WACC7.58%
ROIC/WACC0.49
Cap/Depr(3y)49.8%
Cap/Depr(5y)66.84%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.61%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-68.18%
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.86%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%12.98%
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.21%
EBIT growth 3YN/A
EBIT growth 5Y8.76%
EBIT Next Year101.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3132.56%
FCF growth 3Y113.07%
FCF growth 5YN/A
OCF growth 1Y575.69%
OCF growth 3Y56.62%
OCF growth 5YN/A